StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Ansh Jogendra Bhilwar

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: NA (inferred Intraday)8 Sept 2026, 7:59 am ISTvia Zee Business (Live)

Entry₹2,469.9Inferred
Target₹2,509
Total upside +1.58% (call closed)
Stop loss₹2,425-1.82% risk
At expiry₹2,4798 Sept 2026, 3:05 pm
Expired+0.37%
Follow Ansh Jogendra Bhilwar for new calls(20% target hit, 56 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 8 Sept 2026
1 supporting0 opposing
Supports the BUY call (1)

10 midcap stocks with over 150% profit growth in Q1FY27

NewsEt-Markets·6 Sept · 2d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Ansh Jogendra Bhilwar

Every call and its outcome